Gene · 25833
Papers1,618
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,618
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Small cells - big issues: biological implications and preclinical advancements in small cell lung cancer. | Mol Cancer | 2024 | 38395864 | PubTator, text mining | PubMed |
| C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer. | World J Surg Oncol | 2024 | 38369463 | PubTator, text mining | PubMed |
| [Advances of pathological diagnosis and molecular pathology of lung neuroendocrine neoplasms]. | Zhonghua Bing Li Xue Za Zhi | 2024 | 38281776 | PubTator, text mining | PubMed |
| Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes. | Cancer Cell | 2024 | 38278149 | PubTator, text mining | PubMed |
| Multi-Omics Approach to Improved Diagnosis and Treatment of Atopic Dermatitis and Psoriasis. | Int J Mol Sci | 2024 | 38256115 | PubTator, text mining | PubMed |
| ES-SCLC Patients with PD-L1+ CTCs and High Percentages of CD8+PD-1+T Cells in Circulation Benefit from Front-Line Immunotherapy Treatment. | Biomedicines | 2024 | 38255251 | PubTator, text mining | PubMed |
| Involvement of Lysophospholipids in Pulmonary Vascular Functions and Diseases. | Biomedicines | 2024 | 38255229 | PubTator, text mining | PubMed |
| Predictive biomarkers for immunotherapy response in extensive-stage SCLC. | J Cancer Res Clin Oncol | 2024 | 38245636 | PubTator, text mining | PubMed |
| Induced degradation of lineage-specific oncoproteins drives the therapeutic vulnerability of small cell lung cancer to PARP inhibitors. | Sci Adv | 2024 | 38241363 | PubTator, text mining | PubMed |
| Histopathology images-based deep learning prediction of prognosis and therapeutic response in small cell lung cancer. | NPJ Digit Med | 2024 | 38238410 | PubTator, text mining | PubMed |
| Clinical utility of immunohistochemical subtyping in patients with small cell lung cancer. | Lung Cancer | 2024 | 38232600 | PubTator, text mining | PubMed |
| Transcriptomic-based roadmap to the healthy and ozone-exposed lung. | Curr Opin Toxicol | 2024 | 38187954 | PubTator, text mining | PubMed |
| Paneth-like cells produced from OLFM4+ stem cells support OLFM4+ stem cell growth in advanced colorectal cancer. | Commun Biol | 2024 | 38182890 | PubTator, text mining | PubMed |
| Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies. | Clin Cancer Res | 2024 | 38180245 | PubTator, text mining | PubMed |
| Characterization of two transcriptomic subtypes of marker-null large cell carcinoma of the lung suggests different origin and potential new therapeutic perspectives. | Virchows Arch | 2024 | 38168015 | PubTator, text mining | PubMed |
| NFE2L1/Nrf1 serves as a potential therapeutical target for neurodegenerative diseases. | Redox Biol | 2024 | 38150994 | PubTator, text mining | PubMed |
| Dynamic tuft cell expansion during gastric metaplasia and dysplasia. | J Pathol Clin Res | 2024 | 38117182 | PubTator, text mining | PubMed |
| Advances in new targets for immunotherapy of small cell lung cancer. | Thorac Cancer | 2024 | 38093497 | PubTator, text mining | PubMed |
| A vertebrate-wide catalogue of T1R receptors reveals diversity in taste perception. | Nat Ecol Evol | 2024 | 38093021 | PubTator, text mining | PubMed |
| Application of Small Cell Lung Cancer Molecular Subtyping Markers to Small Cell Neuroendocrine Carcinoma of the Cervix: NEUROD1 as a Poor Prognostic Factor. | Am J Surg Pathol | 2024 | 37981832 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/25833/papers?page=10